Haverkate F - Search Results

1

Normal prevalence of factor V Leiden gene mutation in patients with severe unstable angina.

Verheggen PW, Heymans BT, Slagboom PE, Haverkate F, Cats VM. Verheggen PW, et al. Among authors: haverkate f. Thromb Haemost. 1997 Jun;77(6):1218. Thromb Haemost. 1997. PMID: 9241761 No abstract available.

2

Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris.

de Maat MP, Ossewaarde JM, Verheggen PW, Kluft C, Cats VM, Haverkate F. de Maat MP, et al. Among authors: haverkate f. Atherosclerosis. 2000 Dec;153(2):499-504. doi: 10.1016/s0021-9150(00)00436-6. Atherosclerosis. 2000. PMID: 11164440

3

Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function.

Verheggen PW, de Maat MP, Cats VM, Haverkate F, Zwinderman AH, Kluft C, Bruschke AV. Verheggen PW, et al. Among authors: haverkate f. Eur Heart J. 1999 Apr;20(8):567-74. doi: 10.1053/euhj.1998.1312. Eur Heart J. 1999. PMID: 10337541 Clinical Trial.

4

Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.

Bots ML, van Kooten F, Breteler MM, Slagboom PE, Hofman A, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Bots ML, et al. Among authors: haverkate f. Haemostasis. 1998 May-Aug;28(3-4):209-15. doi: 10.1159/000022432. Haemostasis. 1998. PMID: 10420068

5

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

van der Bom JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Among authors: haverkate f. Ann Intern Med. 1996 Aug 15;125(4):265-9. doi: 10.7326/0003-4819-125-4-199608150-00002. Ann Intern Med. 1996. PMID: 8678388

6

Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.

Haverkate F, Thompson SG, Duckert F. Haverkate F, et al. Thromb Haemost. 1995 Apr;73(4):561-7. Thromb Haemost. 1995. PMID: 7495059

7

The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.

Six AJ, Tjon RM, Buys EM, Haas F, Hollander-van Zalk A, Haverkate F. Six AJ, et al. Among authors: haverkate f. Thromb Haemost. 1990 Aug 13;64(1):113-6. Thromb Haemost. 1990. PMID: 2148844

8

Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.

Haverkate F, Samama M. Haverkate F, et al. Thromb Haemost. 1995 Jan;73(1):151-61. Thromb Haemost. 1995. PMID: 7740487 Review.

9

Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.

Marchi R, Lundberg U, Grimbergen J, Koopman J, Torres A, de Bosch NB, Haverkate F, Arocha Piñango CL. Marchi R, et al. Among authors: haverkate f. Thromb Haemost. 2000 Aug;84(2):263-70. Thromb Haemost. 2000. PMID: 10959699

10

Relationship between CRP and clinical course of unstable angina depends on assay method.

de Maat MP, Haverkate F, Kluft C. de Maat MP, et al. Among authors: haverkate f. Vascul Pharmacol. 2002 Aug;39(3):113-5. doi: 10.1016/s1537-1891(02)00296-3. Vascul Pharmacol. 2002. PMID: 12616976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters